Archive - Sharelock Holmes

Oxford Biodynamics: A Buying Opportunity or Time to Reassess?

Results from the small yet ambitious biotechnology company were mixed—underperformance on the sales front, yet overperformance on the product…

Jan 28, 2024 •

and

A Small Cap with Big Potential: Oxford Biodynamics and the Future of Prostate Cancer Testing

We lay out our expectations for the future of this small UK biotechnology firm, and why we are buyers in Jan 2024.

Jan 14, 2024 •

and

#nojs-banner { position: fixed; bottom: 0; left: 0; padding: 16px 16px 16px 32px; width: 100%; box-sizing: border-box; background: red; color: white; font-family: -apple-system, "Segoe UI", Roboto, Helvetica, Arial, sans-serif, "Apple Color Emoji", "Segoe UI Emoji", "Segoe UI Symbol"; font-size: 13px; line-height: 13px; } #nojs-banner a { color: inherit; text-decoration: underline; } This site requires JavaScript to run correctly. Please turn on JavaScript or unblock scripts